SPY326.54-3.44 -1.04%
DIA265.06-1.53 -0.57%
IXIC10,911.59-274.00 -2.45%

HC Wainwright & Co. Initiates Coverage On Intercept Pharmaceuticals with Neutral Rating, Announces Price Target of $92

HC Wainwright & Co. initiates coverage on Intercept Pharmaceuticals (NASDAQ:ICPT) with a Neutral rating and announces Price Target of $92.

Benzinga · 06/25/2020 10:50
HC Wainwright & Co. initiates coverage on Intercept Pharmaceuticals (NASDAQ: ICPT) with a Neutral rating and announces Price Target of $92.